The Community Hospital of Brazosport

The Community Hospital of Brazosport was paid $8.32M by Medicaid between Jan 2020 and Dec 2024, across 64 billing codes. Its largest line is 99284, emergency room visit (serious) — 51% of everything it billed.

33Billing provider infoTHE COMMUNITY HOSPITAL OF BRAZOSPORT
LAKE JACKSON, TX 77566

33aNPI1972581940assigned 01/09/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$8.32M

24GClaims78,300

24DCodes billed64

24AFirst – last monthJan 2020 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Texas

Rank by total paid#19 of 109

Median peer was paid$1.15M

This provider vs. median7.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	2,473	$210K
2021	20,152	$1.43M
2022	27,463	$2.04M
2023	20,622	$3.06M
2024incomplete	7,590	$1.58M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	51%	8,062	7,707	$4.23M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	29%	9,107	8,905	$2.43M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.4%	989	921	$533K
74177	Computed tomography, abdomen and pelvis; with contrast material	2.3%	270	263	$194K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.9%	1,768	1,601	$158K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.5%	1,608	1,576	$121K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	708	703	$74K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	3,569	1,756	$61K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	380	372	$59K
70450	Computed tomography, head or brain; without contrast material	<1%	398	385	$58K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	8,548	7,586	$54K
71045	Radiologic examination, chest; single view	<1%	1,840	1,698	$50K

52 more codes

80048	Basic metabolic panel (calcium, ionized)	<1%	4,430	$37K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	110	$27K
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,372	$24K
71046	Radiologic examination, chest; 2 views	<1%	267	$20K
96375	Therapeutic injection; each additional sequential IV push	<1%	977	$20K
87070		<1%	1,842	$18K
87081		<1%	2,078	$16K
80053	Comprehensive metabolic panel	<1%	2,320	$14K
80076		<1%	1,730	$13K
81025		<1%	1,361	$13K
0240U		<1%	697	$12K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	365	$11K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	1,419	$11K
83690		<1%	1,418	$7K
96361	Intravenous infusion, hydration; each additional hour	<1%	458	$5K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	47	$5K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	833	$5K
83880		<1%	426	$4K
81001		<1%	1,693	$4K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	1,120	$4K
84484		<1%	933	$4K
87807		<1%	276	$4K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	484	$4K
81003		<1%	1,362	$3K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	57	$3K
85610		<1%	1,098	$2K
83735		<1%	730	$1K
87086	Culture, bacterial; quantitative colony count, urine	<1%	270	$1K
87088		<1%	205	$1K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	17	$995.49
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	16	$982.95
36415	Collection of venous blood by venipuncture	<1%	9,209	$607.34
80329		<1%	14	$515.15
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	335	$458.78
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	117	$357.11
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	30	$324.41
84702		<1%	26	$314.11
80320		<1%	13	$293.80
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	50	$238.71
85730		<1%	111	$177.25
J2270	Injection, morphine sulfate, up to 10 mg	<1%	218	$170.91
84443	Thyroid stimulating hormone (TSH)	<1%	89	$165.77
99218		<1%	14	$153.95
86901		<1%	41	$77.29
86900		<1%	30	$57.47
80061	Lipid panel	<1%	159	$46.03
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	26	$28.96
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	35	$26.73
82947		<1%	14	$18.83
83036	Hemoglobin; glycosylated (A1C)	<1%	70	$15.91
80164		0%	13	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	28	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTRAUTMAN, ROBERT (PRESIDENT)